INTRODUCTION
Lung cancer is the leading cause of cancer mortality worldwide and in Korea (1) (2) (3) (4) . Although cigarette smoking is an established major risk factor for lung cancer, genetic diversity plays an important role in determining the ultimate outcome following exposure to tobacco carcinogens. Non-small cell lung cancer (NSCLC) constitutes the majority of all diagnosed lung cancers in Korea, and adenocarcinoma is the predominant histologic type in NSCLC (5, 6) . Genome-wide association studies (GWASs), based on tagging polymorphisms across the entire genome and usually along with a large sample size and multiple-stage replications, have sufficient power for detecting genetic effects in complex diseases, including lung cancer. Recently, genome-wide studies have identified three susceptibility loci for lung cancer, including the 15q25 (CHRNA 3 -5) (7 -9), 5p15 (hTERT-CLPTM1L) (10, 11) and 6p21 (BAT3-MSH5) (12) regions in European and American populations. The chromosome 15q25 region encoding nicotinic acetylcholine receptor subunits is also thought to be related to nicotine dependence in smokers. However, the minor allele frequencies (MAFs) of single nucleotide polymorphisms (SNPs) in this region were too low in Asians to confirm the results seen in populations of European descent (13, 14) . In addition, McKay et al. (10) identified two independent markers for lung cancer risk: rs2736100 and rs402710, located in TERT and CLPTM1L, respectively. TERT, the reverse transcriptase component of telomerase, is essential for telomerase enzyme production and the maintenance of telomeres, whereas CLPTM1L induces apoptosis of lung cells with genotoxic exposure such as tobacco carcinogen-related stress. Furthermore, the association of rs2736100 on 5p15.33 with lung cancer risk was also shown in Asian populations, including Japanese and Chinese (15, 16) . We hypothesized that novel loci may be identified in a new ongoing GWAS of Korean patients with lung cancer and healthy controls. In this study, we conducted genome-wide screening and a subsequent candidates genotyping study involving 1425 patients and 3011 controls to identify susceptibility markers for NSCLC in the Korean population.
RESULTS

Association analysis
The demographics of the patients with lung cancer and healthy controls are shown in Table 1 .
In the first stage of the GWAS for NSCLC, 621 patients and 1541 controls were genotyped using an Affymetrix 5.0 SNP chip. For quality control, quantile-quantile (Q-Q) plot and principal components analysis (PCA) plot were constructed (Supplementary Material, Fig. S1 ). The measured genetic inflation factor (l ¼ 1.06) and the PCA plot with no outlier revealed minimal overall inflation of the association results due to population stratification. After applying strict quality control criteria, 246 758 genotyped SNPs remained for the subsequent analyses considering the call rate (case .0.97 and CTRL .0.97), MAFs (case .0.05 or CTRL .0.05) and Hardy-Weinberg equilibrium (HWE) (P . ). The association results for the SNPs are shown using a trend P-value plot across the genome (Supplementary Material, Fig. S2 ). In the GWAS data analysis, 168 SNPs showing significant association P-values of less than 10 -4 at stage 1 were selected and subjected to validation (Supplementary Material, Table S1 ). For the replication study, we were able to recruit 804 patients (569 adenocarcinomas and 235 squamous cell carcinomas) and 1470 controls to confirm the results of the GWAS.
In stage 2, rs2131877 at the chromosome 3q29 region showed the most significant association with the lung cancer risk in NSCLC, as well as in the adenocarcinoma group (adjusted P ¼ 7.67 × 10 -5 and 1.95 × 10 -5 in the trend linear model). The combined stage 1 and 2 analyses revealed the enhanced significance of rs2131877 with a P-value of 2.43 × 10 -8 calculated by a meta-analysis using a fixed effects model ( Table 2 ). The effect of rs2131877 remained significant at P , 0.05 after adjustment for tests of 246 758 SNPs with use of the Bonferroni correction. Furthermore, the P-value for rs2131877 passes the threshold for genome-wide significance that was suggested as 7.2 × 10 -8 for two-sided tests of single SNPs in the UK Caucasian population (17, 18) .
Association analysis of SNPs at 3q29
As rs2131877 is located in intron 3 in the C3orf21 gene, we selected tag SNPs from the genomic region around this gene forfine mapping. Additional 28 SNPs were selected on the basis of the frequency (MAF .0.1) and linkage disequilibrium (LD) calculated from the Asian data of the International HapMap Project. Furthermore, we sequenced 10 kb of the Table S2 ). Besides rs2131877, rs10433328, rs952481 and rs4677657 were also significant SNPs that were associated with lung cancer risk in the trend test ( Fig. 1 ). To further evaluate the effects of these four SNPs on lung cancer risk, we performed a subset analysis based on the histologic cell type, as shown in Table 3 . Specifically, the variant genotypes of rs1043328 and rs2131877 were strongly associated with an increased risk of NSCLC when compared with the normal controls [in the linear trend model, adjusted odds ratio (OR) ¼ 1.29, 95% confidence interval (CI) ¼ 1.14-1.46, P ¼ 7.67 × 10 25 and adjusted OR ¼ 1.33, 95% CI ¼ 1.16-1.52, P ¼ 5.39 × 10
25
, respectively]. In the adenocarcinoma group, subjects carrying a variant allele of rs2131877 and rs952481 presented significantly increased risks for lung cancer (trend P ¼ 1.95 × 10 -5 and 3.43 × 10 -4 , respectively). We also tested additional three SNPs-rs2736100, rs402710 and rs401681-that were previously reported as susceptibility markers for lung cancer susceptibility from the population of Western descent. As shown in Table 3 , three markers at 5p15 presented the strong association with lung cancer risk in our samples. After the analyses to test the cumulative effect of these SNPs, we found out that the risk alleles of these seven SNPs increased lung cancer risk in the Korean population (trend P ¼ 3.69 × 10 -11
; Supplementary Material, Table S3 ).
Haplotype analysis
The genotype data of the 32 SNPs were used to estimate the LD block and the haplotype structure at the 3q29 region ( Fig. 1) . Table 4 presents the frequencies of haplotypes for the four significant SNPs (rs952481, rs4677657, rs2131877 and rs10433328) in lung cancer patients and normal controls and estimated the ORs of the lung cancer risk, based on haplotypes controlling for smoking status and age as covariates. From 16 possible haplotypes, six common haplotypes (.5% frequency) were identified with an accumulated frequency of 90.8%. Haplotype GAGC, including minor alleles of these four SNPs, showed the strong association with lung cancer risk (adjusted OR ¼ 1.44, 95% CI ¼ 1.23 -1.69, P ¼ 5.91 × 10 -6 ).
DISCUSSION
Our genome-wide scan and subsequent replication study revealed that polymorphisms at 3q29 showed a significant association with lung cancer, particularly with an increased risk of NSCLC in the Korean population. In 1425 Korean patients with NSCLC and 3011 healthy controls, the strong association with lung cancer risk was observed in markers of the C3orf21 gene at 3q29. From the recent reports of the GWAS for lung cancer, 15q25, 5p15 and 6p21 were identified as the susceptibility loci in the population of European descent (7 -12) . Following studies reported that SNPs at 5p15 were also important in the lung cancer development, especially adenocarcinoma, in both of the Chinese and Japanese populations (15, 16) . As the results of our data, rs2736100 in the TERT gene and rs401681 in the CLPTM1L gene were associated with lung cancer risk in the Korean population. We also identified a cumulative effect of risk alleles among the four markers at 3q29 and the three markers at 5p15, as shown in Supplementary Material, Table S3 . Subjects carrying more than three risk alleles for the seven SNPs had an increasing risk of lung cancer when compared with subjects with less; individuals with no risk alleles of seven SNPs being very rare in our sample set. The region of 3q29 is a previously unreported susceptibility locus for cancer risk as far as we know. Chromosomal imbalance at 3q29 has also been reported in various types of cancer, including NSCLC, prostate cancer and head and neck squamous cell carcinoma (19) (20) (21) . Although the target gene at 3q29 was not sufficiently identified, we suggest C3orf21 as one of the candidate genes based on the associated markers with lung cancer. A strong association was observed for rs2131877 located on the C3orf21 gene, even though there might be an association with another variant in long-range LD or in another gene. The human C3orf21 gene has not been fully characterized, but it is known to be conserved in chimpanzee, cow, mouse, rat, chicken, zebrafish, fruit flyand mosquito (Homologene). The genomic region of C3orf21 is over 202 kb and is predicted to encode protein with 394 amino acids (NP_689744). Further biological analysis of C3orf21 in cancer cells will identify the functional association with cancer. To assess the potential heterogeneity among studies, we tested heterogeneity for risk effect of rs2131877 using Cochran's Q statistic test. There is no heterogeneity between stage 1 and stage 2 (P ¼ 0.84). Significant heterogeneity for the effects of rs2131877 was not detected between adenocarcinoma and squamous cell carcinoma by a case-only test (P ¼ 0.88). As the number of patients with squamous cell carcinoma is much smaller than that of adenocarcinoma patients, the effect of 3q29 on lung cancer according to histologic types should be examined in additional studies with larger sample sizes.
Despite the significant effect of SNPs in 3q29, our study has the limitation considering study population. This study considers only a Korean population, which may limit the application of these findings to other ethnic populations. However, we confirmed the associations of SNPs at 5p15 in the Korean population, and the cumulative association shown in our data could carefully suggest the potential susceptibility markers for lung cancer independent of ethnic background. Further epidemiological studies in larger populations are required to test our hypothesis.
In conclusion, this study constitutes the high-density large-scale GWAS carried out in the Korean population and suggests that 3q29 is a novel susceptibility region associated with lung cancer susceptibility in the Korean population. These results suggest that the presence of the variant allele in C3orf21 is a risk factor for NSCLC and could be an important marker of genetic susceptibility to lung cancer in Koreans.
MATERIALS AND METHODS
Study population
We recruited patients with NSCLC for the GWAS from those patients with histologically confirmed lung cancer who visited the National Cancer Center in Korea and voluntarily participated Figure 1 . Description of the LD structure and the association with lung cancer of 32 SNPs at 3q29. Y-axis of the plot indicates 2log 10 scale of P-value calculated by the Cochrane-Armitage trend test and x-axis indicates the location of SNPs on chromosome 3. Four SNPs strongly associated with lung cancer risk were denoted with rs number. LD structure was obtained by D' using the genotype data in cases and controls. Unconditional logistic regression analyses were adjusted by age, sex and smoking status as covariates. Trend P-value was calculated by the linear trend model using a continuous variable for the number of risk alleles.
in a health questionnaire survey conducted from May 2002 to December 2005. They donated blood for genetic tests after signing an informed consent form that was approved by the Institutional Review Board. No recruitment restrictions were imposed with regard to gender or cancer stage. None of these patients with cancer had received chemotherapy or radiotherapy before their recruitment. For comparison, 1541 control subjects with no history of cancer were matched with the patients for age and gender. GWAS data and demographic characteristics, including gender, age and smoking habits, for these control subjects were kindly provided by the Korea Association Resource (KARE) project (22) . The control subjects were recruited from a population-based cohort study that was conducted by the National Institute of Health, Korea. Control subjects for a replication study were recruited from individuals who visited National Cancer Center for a cancer screening program.
Genotyping
Genomic DNA was extracted from peripheral blood using a QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA, USA) in accordance with the manufacturer's instructions. Genome-wide, high-density SNP screening was performed in 2162 subjects using the Affymetrix Genome-Wide Human SNP array 5.0 (Affymetrix, Santa Clara, CA, USA). Genotyping for the replication study and fine mapping were carried out using TaqMan probe genotyping (Applied Biosystems, Foster City, CA, USA) or a multiplex-PCR-based Invader assay (Third Wave Technologies, Madison, WI, USA). We also resequenced the candidate region in 48 healthy controls to discover new SNPs for fine mapping.
Statistical analysis
To test the differences in demographic characteristics between cases and controls, Pearson's x 2 test categorical variables and the Wilcoxon rank-sum test were performed for continuous variables. Regarding smoking habits, former and present smokers were defined as ever smokers. Never smokers were defined as subjects who had smoked less than 100 cigarettes during their lifetime.
SNPs with duplicate errors or a minimum call rate under 97% were excluded from the statistical analysis. The MAF of SNPs for subsequent analyses should exceed 5% in the case or control group. The genotyping results of the controls were tested for HWE. If a polymorphism was not in HWE (P , 0.0001), it was also excluded from further analysis. Q -Q plots were used to evaluate the overall significance of the GWAS data, and a PCA plot was used to examine any population stratification (23, 24) . The association of genotyped SNPs and lung cancer risk was analyzed using PLINK (25) .
We employed a widely used measure of LD between all pairs of biallelic loci, Lewontin's D ′ (|D ′ |) (26) and r
2
. LD blocks were identified using Haploview software (27) . The |D ′ | values for all pairs of SNPs were calculated, and the haplotype blocks were estimated using the confidence interval method (28) . Haplotypes for each block and individual were inferred using the algorithm developed by Stephens et al. (29) , which uses a Bayesian approach incorporating a priori expectations for haplotype reconstruction. This software calculated the phase probabilities of each site for each individual, and the haplotype with the highest probability for each sample was used for the subsequent analysis. The genetic effects of the inferred haplotypes were analyzed in the same way as the SNPs. The relationship between polymorphisms and the lung cancer risk was analyzed using multiple logistic regression models while controlling for age and smoking status as covariates. We also analyzed the association between polymorphisms and the risk of adenocarcinoma and squamous cell carcinoma, which were the two most common histologic types in our study subjects. The associations between haplotype and the lung cancer risk were analyzed using logistic regression at the individual level, in which the covariate was defined by the number of copies (0, 1 or 2) of each haplotype that a subject carried. All reported P-values are two-sided. The statistical software Stata/SE version 10 was used for statistical analyses (StataCorp LP, College Station, TX, USA). 
